PMID- 24038092 OWN - NLM STAT- MEDLINE DCOM- 20131210 LR - 20220311 IS - 1550-6606 (Electronic) IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 191 IP - 8 DP - 2013 Oct 15 TI - Interruption of dendritic cell-mediated TIM-4 signaling induces regulatory T cells and promotes skin allograft survival. PG - 4447-55 LID - 10.4049/jimmunol.1300992 [doi] AB - Dendritic cells (DCs) are the central architects of the immune response, inducing inflammatory or tolerogenic immunity, dependent on their activation status. As such, DCs are highly attractive therapeutic targets and may hold the potential to control detrimental immune responses. TIM-4, expressed on APCs, has complex functions in vivo, acting both as a costimulatory molecule and a phosphatidylserine receptor. The effect of TIM-4 costimulation on T cell activation remains unclear. In this study, we demonstrate that Ab blockade of DC-expressed TIM-4 leads to increased induction of induced regulatory T cells (iTregs) from naive CD4(+) T cells, both in vitro and in vivo. iTreg induction occurs through suppression of IL-4/STAT6/Gata3-induced Th2 differentiation. In addition, blockade of TIM-4 on previously activated DCs still leads to increased iTreg induction. iTregs induced under TIM-4 blockade have equivalent potency to control and, upon adoptive transfer, significantly prolong skin allograft survival in vivo. In RAG(-/-) recipients of skin allografts adoptively transferred with CD4(+) T cells, we show that TIM-4 blockade in vivo is associated with a 3-fold prolongation in allograft survival. Furthermore, in this mouse model of skin transplantation, increased induction of allospecific iTregs and a reduction in T effector responses were observed, with decreased Th1 and Th2 responses. This enhanced allograft survival and protolerogenic skewing of the alloresponse is critically dependent on conversion of naive CD4(+) to Tregs in vivo. Collectively, these studies identify blockade of DC-expressed TIM-4 as a novel strategy that holds the capacity to induce regulatory immunity in vivo. FAU - Yeung, Melissa Y AU - Yeung MY AD - Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02445; FAU - McGrath, Martina M AU - McGrath MM FAU - Nakayama, Masafumi AU - Nakayama M FAU - Shimizu, Tetsunosuke AU - Shimizu T FAU - Boenisch, Olaf AU - Boenisch O FAU - Magee, Ciara N AU - Magee CN FAU - Abdoli, Rozita AU - Abdoli R FAU - Akiba, Hisaya AU - Akiba H FAU - Ueno, Takuya AU - Ueno T FAU - Turka, Laurence A AU - Turka LA FAU - Najafian, Nader AU - Najafian N LA - eng GR - R56 AI101150/AI/NIAID NIH HHS/United States GR - R56 AI089777/AI/NIAID NIH HHS/United States GR - R56 AI101150-0141/AI/NIAID NIH HHS/United States GR - R01 AI037691/AI/NIAID NIH HHS/United States GR - R01AI037691-17A1/AI/NIAID NIH HHS/United States GR - R56AI089777-01A1/AI/NIAID NIH HHS/United States GR - T32 DK007527/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130913 PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Antibodies, Monoclonal) RN - 0 (GATA3 Transcription Factor) RN - 0 (Gata3 protein, mouse) RN - 0 (Homeodomain Proteins) RN - 0 (Membrane Proteins) RN - 0 (STAT6 Transcription Factor) RN - 0 (Stat6 protein, mouse) RN - 0 (TIM-4 protein, mouse) RN - 128559-51-3 (RAG-1 protein) RN - 207137-56-2 (Interleukin-4) SB - IM MH - Adoptive Transfer MH - Allografts/immunology MH - Animals MH - Antibodies, Monoclonal/immunology MH - Cell Differentiation/immunology MH - Cells, Cultured MH - Dendritic Cells/*immunology MH - GATA3 Transcription Factor/immunology MH - *Graft Survival MH - Homeodomain Proteins/genetics MH - Interleukin-4/immunology MH - Lymphocyte Activation MH - Membrane Proteins/immunology/*metabolism MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - STAT6 Transcription Factor/immunology MH - Signal Transduction MH - *Skin Transplantation MH - T-Lymphocytes, Regulatory/*immunology/metabolism MH - Th1 Cells/immunology MH - Th2 Cells/immunology PMC - PMC3804420 MID - NIHMS515004 EDAT- 2013/09/17 06:00 MHDA- 2013/12/16 06:00 PMCR- 2014/10/15 CRDT- 2013/09/17 06:00 PHST- 2013/09/17 06:00 [entrez] PHST- 2013/09/17 06:00 [pubmed] PHST- 2013/12/16 06:00 [medline] PHST- 2014/10/15 00:00 [pmc-release] AID - jimmunol.1300992 [pii] AID - 10.4049/jimmunol.1300992 [doi] PST - ppublish SO - J Immunol. 2013 Oct 15;191(8):4447-55. doi: 10.4049/jimmunol.1300992. Epub 2013 Sep 13.